Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMA trial: DP, MAS3, and ALN+ for malaria in pregnancy
NCT01054248Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Feb 2010
- Primary completion
- Sep 2016
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine, artesunate + mefloquine in malaria, sponsored by University of Oxford. Started Feb 2010; status: completed.
02
Drugs
dihydroartemisinin + piperaquineartesunate + mefloquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01054248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01054248.